Patients with Systemic Sclerosis (SS), also known as scleroderma, have the highest risk of developing pulmonary arterial hypertension (PAH), according to…
Articles by Patricia Inácio, PhD
In a new study entitled “Subclinical atherosclerosis and peripheral vascular disease in systemic sclerosis patients: Relation…
A new clinical trial on Systemic Sclerosis (also known as Scleroderma) is now recruiting participants – adult patients (at…
In a recent study entitled “Scleroderma renal crisis,” the authors summarize the most recent findings related…
In a study entitled “A Case Report of Living-donor Lobar Lung Transplantation for Scleroderma-associated Usual Interstitial…
In a recent study entitled “Decreased numbers of endothelial progenitor cells in patients in the early stages…
The American College of Rheumatology (ACR), together with the European League Against Rheumatism (EULAR) published new criteria for classification…
New research presented at the American College of Rheumatology Annual Meeting in Boston highlights that patients with systemic sclerosis with end-stage…
Those in the Scleroderma community are taking note of recent news that Bayer HealthCare will be initiating a randomized, double-blind, placebo-controlled,…
Inventiva Pharma’s lead product, IVA337, recently received a positive review by The European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products…